Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies. - Park YH; Cortes J; Modi S; Hurvitz SA; Bianchini G; Iwata H; Shitara K; Siena S; Goto Y; Ku GY; Powell CA; Swain SM; et al. (The oncologist, 2025)